Clinical Trial Update: Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating molecular neuroimaging to link neuroinflammation with cognitive impairment in breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Breast Cancer | Phase 1 | Status: WITHDRAWN